ClinicalTrials.Veeva

Menu

Daily Low-level Red Light and 0.01% Low-dose Atropine for Myopia Prevention

Capital Medical University logo

Capital Medical University

Status

Completed

Conditions

Myopia

Treatments

Drug: Atropine (0.01%)
Device: low-level red-light

Study type

Interventional

Funder types

Other

Identifiers

NCT06727019
BeijingTH2023qiao

Details and patient eligibility

About

To compare the preventive effects of daily low-level red-light and 0.01% low-dose atropine eye drops on myopia.

Enrollment

138 patients

Sex

All

Ages

7 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. Aged at least 7 years old. 2. The spherical equivalent error (SER) after pupil dilation was between -0.5 D and +0.75D.

    2. Had a record of cycloplegia SER at least 6 months before this study, and SER changed -0.5D compared with the last measurement or had a family history of high myopia.

    3. Corneal astigmatism ≤ 1.25D. 5. Interocular refraction discrepancy ≤ 1.5D. 6. No allergy history of cycloplegia drugs. 7. Willingness to participate in the study and signed informed consent.

Exclusion criteria

    1. Intraocular pressure was below 10 mm Hg or higher than 22 mm Hg. 2. Presence of amblyopia, or ocular pathological conditions such as retinal, lens, or corneal disorders.
  1. Children currently using other myopia interventions other than LDA or LLRL. 4. Children with systemic and immune disorders, such as albinism, psoriasis, nephrotic syndrome, systemic lupus erythematosus, and diabetes 5. Individuals with conditions like Tourette's syndrome or epilepsy.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

138 participants in 2 patient groups

red-light
Experimental group
Description:
In the low-level red-light (LLRL) group, the children used LLRL irradiation twice a day for 3-minute sessions, ensuring a gap of over 4 h between each use
Treatment:
Device: low-level red-light
atropine
Experimental group
Description:
participants in the atropine group used 0.01% low-dose atropine eye drops once each night
Treatment:
Drug: Atropine (0.01%)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems